Tomato products may protect against inflammation, according to data from a recent multicenter, randomized, controlled trial. The team of US researchers who conducted the study also found that processed tomato products had a beneficial effect on vasodilatation and inflammatory mediator C-reactive protein in overweight and obese subjects.
Within the diets of 56 healthy volunteers who took part in the study, processed tomato products or non-tomato products were matched in calories, sodium and sugar content. All of the test subjects consumed a low-tomato diet for three weeks followed by either a six-week high-tomato diet or low-tomato diet. At six weeks, the subjects were assessed as to the response of tomato after eating a high-fat meal. Compared with the low-tomato group, the high-tomato arm experienced a C-reactive protein level that was lower in response to the high-fat meal. High-tomato intake was also associated with increased mean vessel diameter, but flow mediated vasodilatation was not different, possibly related to the Body Mass Index of subjects.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze